BE, N., A, d. N., N, C., L, H., MP, d. S., K, C., . . . WS, S. (2024). Ten-year health impact, economic impact and return on investment of the South African molecular diagnostics programme for HIV, tuberculosis and SARS-CoV-2. BMJ global health, 9(12), . https://doi.org/10.1136/bmjgh-2024-015830
Chicago Style (17th ed.) CitationBE, Nichols, et al. "Ten-year Health Impact, Economic Impact and Return on Investment of the South African Molecular Diagnostics Programme for HIV, Tuberculosis and SARS-CoV-2." BMJ Global Health 9, no. 12 (2024). https://doi.org/10.1136/bmjgh-2024-015830.
MLA (9th ed.) CitationBE, Nichols, et al. "Ten-year Health Impact, Economic Impact and Return on Investment of the South African Molecular Diagnostics Programme for HIV, Tuberculosis and SARS-CoV-2." BMJ Global Health, vol. 9, no. 12, 2024, https://doi.org/10.1136/bmjgh-2024-015830.